| Darin Keith Wilbourn, MD | |
|
410 W Pershing Blvd, North Little Rock, AR 72114-2146 | |
| (501) 771-0674 | |
| (501) 753-4174 |
| Full Name | Darin Keith Wilbourn |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 31 Years |
| Location | 410 W Pershing Blvd, North Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770561532 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | C8478 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health - Fort Smith | Fort smith, AR | Hospital |
| Mercy Hospital Fort Smith | Fort smith, AR | Hospital |
| Sequoyah County-city Of Sallisaw Hospital Authorit | Sallisaw, OK | Hospital |
| Entity Name | Little Rock Spine & Joint Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982715074 PECOS PAC ID: 9638383268 Enrollment ID: O20110318000658 |
News Archive
Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.
University at Buffalo researchers are creating a new and unusual "app" for the smart phone: tracking air pollution.
Scientists have provided new insights into how the brain is organised - knowledge which could eventually inform diagnosis of and treatments for conditions like Alzheimer's disease and autism.
Megan Matthews thought she was dying. "I thought my head was blown off," said Matthews, 22, who was hit in the eye with a sponge-tipped projectile fired by law enforcement at a May 29 protest in Denver. "Everything was dark. I couldn't see."
An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier and kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darin Keith Wilbourn, MD 410 W Pershing Blvd, North Little Rock, AR 72114-2146 Ph: (501) 771-0674 | Darin Keith Wilbourn, MD 410 W Pershing Blvd, North Little Rock, AR 72114-2146 Ph: (501) 771-0674 |
News Archive
Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.
University at Buffalo researchers are creating a new and unusual "app" for the smart phone: tracking air pollution.
Scientists have provided new insights into how the brain is organised - knowledge which could eventually inform diagnosis of and treatments for conditions like Alzheimer's disease and autism.
Megan Matthews thought she was dying. "I thought my head was blown off," said Matthews, 22, who was hit in the eye with a sponge-tipped projectile fired by law enforcement at a May 29 protest in Denver. "Everything was dark. I couldn't see."
An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier and kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).
› Verified 8 days ago
Dr. Matthew Elton Goodwin, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2200 Fort Roots Dr, Pm&rs (117/nlr), North Little Rock, AR 72114 Phone: 501-257-2991 | |
Dr. Richard P Gray, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2200 Fort Roots Dr, Pm&rs 117/nlr, North Little Rock, AR 72114 Phone: 501-257-2992 Fax: 501-257-2993 | |
Eric Everson, PT DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4801 Fairway Ave, North Little Rock, AR 72116 Phone: 501-758-1300 | |
Dr. Alice Virginia Fann, M.D., PH.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2200 Fort Roots Dr, Rt 117/nlr, North Little Rock, AR 72114 Phone: 501-257-2995 Fax: 501-257-2993 | |
Joshua Ferguson, PT. DPT. CSCS Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4801 Fairway Ave, North Little Rock, AR 72116 Phone: 501-758-1300 Fax: 501-758-1316 | |
Dr. Jose Dan Octoso Escarda, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2200 Fort Roots Dr, Pmr&s(117/nlr), North Little Rock, AR 72114 Phone: 501-257-2992 Fax: 501-257-2993 | |
Mr. Kevin Jerome Collins, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3401 Springhill Drive, Suite 460, North Little Rock, AR 72117 Phone: 501-945-1888 Fax: 501-945-4102 |